Bookmark

Add to MyYahoo RSS

Merck News

News on Merck (Ticker: MRK) continually updated from thousands of sources around the net.

1 hr ago | Hispanic Business

Idenix Pharmaceuticals Inc - 10-Q - Management's Discussion and...

This report contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.

Comment?

Related Topix: Biotech, Medicine, Idenix Pharmaceuticals, Healthcare Industry, Corporate / Securities Law, Law

12 hrs ago | Reuters

AstraZeneca steps up push into cancer immunotherapy

AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumour types.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Health, Lung Cancer, Oncology

Wed Jul 30, 2014

Investor's Business Daily

Merck, J&J, Baxter Provide Healthy Dividend Stream

But earnings climbed 1% to 85 cents a share for its third straight quarter of gains.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food, J and J Snack Foods

GuruFocus.com

Vanguard Health Care Fund's Top Second Quarter Stocks

Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Bristol-Myers Squibb, Pharmaceuticals

Live Charts

US close: Stocks slip as Russia sanctions weigh

Mid-session the European Union agreed to impose new sanctions on Russia for its involvement in the fighting in Ukraine, with measures to prevent Russian banks from accessing European capital markets or taking loans from their European peers, as well as restrictions on access to sensitive technology and equipment for the oil industry.

Comment?

Related Topix: Financial Markets, Vladimir Putin, Biotech, Medicine, Healthcare Industry, Pfizer

Seeking Alpha

Merck's (MRK) CEO Lynn Fuller on Q2 2014 Results - Earnings Call Transcript

Good day everyone, and welcome to Merck's Second Quarter 2014 Earnings Conference Call.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fox News

U.S. Futures Tick Higher on Earnings, Ahead of Data

U.S. stock index futures edged higher on Tuesday following better-than-expected results from companies such as Pfizer and Merck and ahead of data on home prices and consumer sentiment.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Housing, Business News

Barron's

Morning Movers: BP, UPS, Drugmakers

Russia's bad behavior is having an impact on integrated oil giant BP , which warned that increasing Western sanctions on Russia could hurt given its nearly 20% stake in state oil company Rosneft.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Aetna, Insurance, Financial Markets

Tue Jul 29, 2014

Customer Interaction Solutions

Merck Announces Second-Quarter 2014 Financial Results

Merck , known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Zetia, Ezetimibe (generic), Diabetes, Health

BioSpace

Merck & Co., Inc. Second Quarter Profit More Than Doubles As Newer Drugs Offset Generics

Merck Announces Second-Quarter 2014 Financial Results * Second-Quarter 2014 Non-GAAP EPS of $0.85, Excluding Certain Items, and GAAP EPS of $0.68 * 2014 Full-Year Non-GAAP EPS Target of $3.43 to $3.53, Excluding Potential Venezuelan Bolivar Devaluation and Certain Other Items; 2014 Full-Year GAAP EPS Target of $4.44 to $4.77 * 2014 Full-Year ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Barron's

Merck Pops On Good Profits, Tax Deal?

Even though Merck doesn't plan an international marriage to cut its tax bill, its shares are rallying today on solid results in the latest quarter.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology, Financial Markets

WKXW-FM Trenton

Merck's 2nd Quarter profit more than doubles

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double second-quarter profit, improve its profit forecast and top analysts' expectations.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Whitehouse Station, NJ

Newsday

Earnings: UPS profit slides; Pfizer tops estimates; Merck doubles; Aetna inches higher

United Parcel Service driver Marty Thompson starts his truck up after making a delivery in Cumming, Ga.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Transportation, Trucking, United Parcel Service, Air Courier, Expedited Group, Cumming, GA, Forsyth County, GA

Ledger-Enquirer.com

Merck 2Q profit more than doubles

The Whitehouse Station, New Jersey-based company said net income increased to $2 billion, or 68 cents per share, from $906 million, or 30 cents per share, in the same quarter a year earlier.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Whitehouse Station, NJ

WTHR-TV Indianapolis

Merck 2Q profit more than doubles

Most of the 1,200 people driven to evacuate by a Northern California wildfire that destroyed 13 homes have been told they can safely return after a series of steady gains in the firefight.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Natural Disasters, Wildfire, Fire, US News, US Supreme Court

Castanet.net

Merck second-quarter profit more than doubles, tops forecast

The Whitehouse Station, New Jersey-based company said net income increased to $2 billion, or 68 cents per share, from $906 million, or 30 cents per share, in the same quarter a year earlier.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Whitehouse Station, NJ

Mon Jul 28, 2014

Forbes.com

Interesting September Stock Options for Merck

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co ., Inc .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Seeking Alpha

Why Merck Is Heading To $65

Management has not lost focus. Merck has a plan to attack and grow its share in immuno-oncologyand entering/dominating the hepatitis C and vaccines market.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Hepatitis, Johnson and Johnson, Gilead Sciences

Business Journal

Merck cutting 600 jobs

Merck & Co . Inc. is laying off 600 workers in Pennsylvania by the end of August, according to a notice the pharmaceutical company filed with the Pennsylvania Department of Labor and Industry.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, West-Point, PA

Sun Jul 27, 2014

West Australian

Pfizer's need for deal looms larger with earnings report

While many industry watchers expect Pfizer to re-engage with Britain's AstraZeneca in coming months, some say the U.S. drugmaker should consider targets more focussed on biotechnology, a strategy that has paid off for Merck & Co Although Pfizer is conducting trials of promising products - including breast cancer drug palbociclib and vaccines ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Health, Breast Cancer, Cancer

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••